Quantum Immunologics’ Alternative to Chemotherapy

The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.

Read more »

Quantum Immunologics at the 2010 OneMedForum

Charles Broes, CEO and Chairman of the Board of Quantum Immunologics, discusses his company with OneMedTV correspondent Alicia Ontiveros at […]

Read more »